 "coronavirus, covid-19, vaccine, vaccination, women")
Indian SARS-CoV-2 Genomics Consortium (INSACOG) has clarified that it has not recommended or suggested a booster dose in the national immunisation programme and that suggestions regarding vaccines, their schedule, and roll out is an express mandate of the National Technical Advisory Group on Immunization (NTAGI) and National Expert Group on Vaccine Administration for Covid-19 (NEGVAC).
In its latest newsletter INSACOG has said that immunity and protection from SARS-CoV-2 is multifactorial with several unknown factors and further compounded by emerging variants of concern. “Many more scientific experiments are needed to assess the impacts of booster dose, which are being guided and
